Published in Mol Cell Biol on September 01, 1999
Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer (2009) 4.66
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood (2009) 2.26
A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc Natl Acad Sci U S A (2005) 1.64
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem (2011) 1.63
E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep (2005) 1.51
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci U S A (2000) 1.45
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood (2010) 1.28
ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol (2002) 1.07
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol (2000) 1.06
Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet (2010) 1.04
Comparative analysis of E2F family member oncogenic activity. PLoS One (2007) 1.04
Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J Cell Biol (2002) 1.02
Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proc Natl Acad Sci U S A (2003) 1.02
Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein. Mol Cell Biol (2000) 0.94
Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res (2009) 0.93
The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development. Cancer Discov (2015) 0.87
Repression of androgen receptor transcription through the E2F1/DNMT1 axis. PLoS One (2011) 0.86
Bioinformatic detection of E47, E2F1 and SREBP1 transcription factors as potential regulators of genes associated to acquisition of endometrial receptivity. Reprod Biol Endocrinol (2011) 0.85
Signalling in the epidermis: the E2F cell cycle regulatory pathway in epidermal morphogenesis, regeneration and transformation. Int J Biol Sci (2005) 0.84
Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. J Clin Pathol (2005) 0.83
E2F activators signal and maintain centrosome amplification in breast cancer cells. Mol Cell Biol (2014) 0.83
Surprising dependency for retinoblastoma protein in ras-mediated tumorigenesis. Mol Cell Biol (2006) 0.83
Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer. Mol Cancer (2010) 0.82
Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy. Future Oncol (2010) 0.82
The role of the E2F transcription factor family in UV-induced apoptosis. Int J Mol Sci (2011) 0.81
Skin Tumors Rb(eing) Uncovered. Front Oncol (2013) 0.80
Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation (2008) 0.79
A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling. Stem Cell Rev (2010) 0.78
To live or let die - complexity within the E2F1 pathway. Mol Cell Oncol (2015) 0.78
p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia. Oncogene (2013) 0.78
The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis. Oncotarget (2015) 0.77
Knockdown of E2f1 by RNA interference impairs proliferation of rat cells in vitro. Genet Mol Biol (2010) 0.75
Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer. Mol Med Rep (2016) 0.75
The miR-106a~363(Xpcl1) miRNA cluster induces murine T cell lymphoma despite transcriptional activation of the p27(Kip1) cell cycle inhibitor. Oncotarget (2017) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Cancer cell cycles. Science (1996) 21.29
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (1986) 6.14
Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A (1997) 5.83
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53
Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A (1994) 2.24
v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A (1990) 2.16
Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J (1994) 2.14
Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell (1998) 2.02
Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86
Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem (1995) 1.79
Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene (1994) 1.38
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A (1998) 1.38
Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J Biol Chem (1995) 1.26
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene (1998) 1.25
Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene (1993) 1.22
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med (1998) 1.18
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (1995) 1.14
Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res (1997) 1.07
Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene (1998) 1.05
A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res (1998) 0.95
Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol Carcinog (1997) 0.93
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci (1975) 4.32
Practice patterns of black physicians: results of a survey of Howard University College of Medicine alumni. J Natl Med Assoc (1982) 2.99
Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol (1996) 2.65
Induction of cyclin D1 overexpression by activated ras. Oncogene (1994) 2.35
Survey of graduates of a traditionally black college of medicine. J Med Educ (1978) 2.24
Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension (1993) 2.19
Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A (1998) 2.10
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Bronchoscopic removal of aspirated foreign bodies in children. J Pediatr Surg (1994) 1.92
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev (1998) 1.88
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J Virol (2000) 1.88
Arterial baroreceptor reflex modulation of sympathetic-cardiovascular adjustments to heat stress. Hypertension (1990) 1.82
Recruitment and progress of minority medical school entrants 1970-1972. J Med Educ (1975) 1.76
A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol (1993) 1.70
Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves. Science (1971) 1.68
The modified injury severity scale in pediatric multiple trauma patients. J Pediatr Surg (1980) 1.66
Augmenting local bone with Grafton demineralized bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopedics (2000) 1.63
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene (1998) 1.61
Excessive mortality and causes of death in morbidly obese men. JAMA (1980) 1.60
Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. Am J Pathol (1991) 1.59
High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57
Determination of the primary charge separation rate in isolated photosystem II reaction centers with 500-fs time resolution. Proc Natl Acad Sci U S A (1989) 1.55
Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol (1985) (1989) 1.55
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst (1993) 1.54
Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci U S A (1996) 1.51
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol (1999) 1.46
Predicting academic performance at a predominantly black medical school. J Med Educ (1986) 1.45
The risk of sudden infant death from gastroesophageal reflux. J Pediatr Surg (1991) 1.44
Gynecomastia with ketoconazole. Antimicrob Agents Chemother (1981) 1.42
Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. J Mol Biol (1999) 1.42
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A (1998) 1.38
An assessment of gastroesophageal reflux in children by extended pH monitoring of the distal esophagus. Surgery (1978) 1.38
Enhanced release of dopamine- -hydroxylase from sympathetic nerves by calcium and phenoxybenzamine and its reversal by prostaglandins. Proc Natl Acad Sci U S A (1971) 1.37
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet (2001) 1.28
Pulmonary sequestration in infants and children: a 20-year experience and review of the literature. J Pediatr Surg (1970) 1.25
Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein. J Virol (1999) 1.25
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene (1998) 1.25
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A (1994) 1.24
Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res (1994) 1.23
Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene (1993) 1.22
A large teratoma of the hard palate: a case report. Br J Oral Maxillofac Surg (2008) 1.22
Esophageal pH monitoring during sleep identifies children with respiratory symptoms from gastroesophageal reflux. Gastroenterology (1981) 1.20
Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc Natl Acad Sci U S A (1990) 1.20
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci U S A (1987) 1.19
Gastroschisis and omphalocele. An eight-year review. Ann Surg (1980) 1.19
Diaphragmatic hernia in infancy: factors affecting the mortality rate. Surgery (1967) 1.19
A sensitive radioimmunoassay for 7S nerve growth factor antigens in serum and tissues. J Neurochem (1971) 1.19
Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science (1982) 1.18
The influence of extracorporeal handling of blood on hemorrhagic shock in dogs. Exp Med Surg (1965) 1.18
Assessment of total head excursion and resting head posture. Arch Phys Med Rehabil (1991) 1.18
The study of applicants, 1964-65. J Med Educ (1965) 1.17
Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem (2000) 1.17
Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ (1996) 1.15
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (1995) 1.14
Ga-67 uptake in the lung in sarcoidosis. Radiology (1984) 1.14
Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol (1994) 1.14
The role of nerve growth factor in the ramification of sympathetic nerve fibres into the rat iris in organ culture. J Neurochem (1972) 1.13
Plasma norepinephrine responses of man in cold water. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.13
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res (1996) 1.13
ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development. Mol Carcinog (1999) 1.12
cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig. J Immunol (1993) 1.12
Special report. Air transport of pediatric emergency cases. N Engl J Med (1982) 1.11
A variant of pulmonary alveolar microlithiasis in nackt mice. Vet Pathol (2002) 1.11
Tonic sympathetic support of metabolic rate is attenuated with age, sedentary lifestyle, and female sex in healthy adults. J Clin Endocrinol Metab (2001) 1.11
Role of E2F in cell cycle control and cancer. Front Biosci (1998) 1.11
Study of U.S. medical school applicants, 1976--77. J Med Educ (1978) 1.10
Childhood gastroesophageal reflux. Neurologic and psychiatric syndromes mimicked. JAMA (1977) 1.10
Hyperoxia lowers sympathetic activity at rest but not during exercise in humans. Am J Physiol (1991) 1.09
Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins. Antimicrob Agents Chemother (1983) 1.09
Sympathoadrenal-circulatory regulation during sustained isometric exercise in young and older men. Am J Physiol (1991) 1.08
Augmented forearm vasoconstriction during dynamic exercise in healthy older men. Circulation (1992) 1.08
Gastrointestinal function after surgical correction of Hirschsprung's disease: long-term follow-up in 135 patients. J Pediatr Surg (1995) 1.07
The AAMC study of medical student attrition: overview and major findings. J Med Educ (1965) 1.07
Retention by sex and race of 1968-1972 U.S. medical school entrants. J Med Educ (1975) 1.07
Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog (1989) 1.06
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol (2000) 1.06
Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis (1986) 1.06
Long-term follow-up of surgery for gastroesophageal reflux in infants and children. J Pediatr (1983) 1.06
Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. Oncogene (1998) 1.06
Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. Am J Pathol (2001) 1.05
Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin. Mol Carcinog (1999) 1.05
Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene (1995) 1.05
Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene (1998) 1.05